It is time to reconsider leukoreduction of whole blood for use in patients with life‐threatening hemorrhage

Documenti analoghi

• Revisiting whole blood transfusion for the massively bleeding patient: The origins of resistance to change
  di: Evan M. Bloch, et al.
  Pubblicazione: (2025)
• A new look at an old warning: Transfusing ABO group‐specific red blood cells after large‐volume low‐titer group O whole blood in trauma resuscitation
  di: Mark H. Yazer, et al.
  Pubblicazione: (2025)
• Low titer group O whole blood inventory conservation: The effect of implementing group A whole blood at a simulated civilian trauma center
  di: Emilie A. Jochumsen, et al.
  Pubblicazione: (2026)
• Survey of quality control testing practices on low titer group O whole blood in the United States
  di: Mark H. Yazer, et al.
  Pubblicazione: (2026)
• The THOR network best practices for females of childbearing potential with life‐threatening hemorrhage: Guidance for emergency medical services and hospitals
  di: Matthew J. Levy, et al.
  Pubblicazione: (2026)